tiprankstipranks
Luye Pharma Group (LYPHF)
:LYPHF
US Market

Luye Pharma Group (LYPHF) Technical Analysis

Compare
3 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
6Neutral
10Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Luye Pharma Group ’s (LYPHF) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Luye Pharma Group is a Sell.
Luye Pharma Group ’s (LYPHF) 20-Day exponential moving average is 0.29, while Luye Pharma Group ’s (LYPHF) share price is $0.3, making it a Buy.
Luye Pharma Group ’s (LYPHF) 50-Day exponential moving average is 0.29, while Luye Pharma Group ’s (LYPHF) share price is $0.3, making it a Buy.

Luye Pharma Group (LYPHF) Pivot Points

Mar 04, 2025, 03:46 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.18
0.22
0.26
0.30
0.34
0.38
0.42
Fibonacci
0.22
0.25
0.27
0.30
0.33
0.35
0.38
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Luye Pharma Group (LYPHF) Moving Averages

Mar 04, 2025, 03:46 PM
Period
Simple
Exponential
MA5
0.31Sell
0.30Sell
MA10
0.30Sell
0.30Sell
MA20
0.29Buy
0.29Buy
MA50
0.28Buy
0.29Buy
MA100
0.32Sell
0.31Sell
MA200
0.34Sell
0.33Sell
Luye Pharma Group ’s (LYPHF) 10-Day exponential moving average is 0.30, while Luye Pharma Group ’s (LYPHF) share price is $0.3, making it a Sell.
Luye Pharma Group ’s (LYPHF) 100-Day exponential moving average is 0.31, while Luye Pharma Group ’s (LYPHF) share price is $0.3, making it a Sell.
Luye Pharma Group ’s (LYPHF) stock price is $0.3 and Luye Pharma Group ’s (LYPHF) 50-day simple moving average is 0.28, creating a Buy signal.
Luye Pharma Group ’s (LYPHF) stock price is $0.3 and Luye Pharma Group ’s (LYPHF) 100-day simple moving average is 0.32, creating a Sell signal.
Luye Pharma Group ’s (LYPHF) stock price is $0.3 and Luye Pharma Group ’s (LYPHF) 200-day simple moving average is 0.34, creating a Sell signal.

Luye Pharma Group (LYPHF) Technical Indicators

Mar 04, 2025, 03:46 PM
Name
Value
Implied Action
RSI (14)
55.77
Neutral
STOCH (9,6)
49.98
Neutral
STOCHRSI (14)
57.70
Neutral
MACD (12,26)
<0.01
Sell
ADX (14)
31.64
Neutral
Williams %R
-47.90
Buy
CCI (14)
37.95
Neutral
ATR (14)
0.08
-
Ultimate Oscillator
50.65
Neutral
ROC
3.45
Buy
Luye Pharma Group ’s (LYPHF) Relative Strength Index (RSI) is 55.77, creating a Neutral signal.
Luye Pharma Group ’s (LYPHF) Trend Strength Indicator (ADX) is 31.64, creating a Neutral signal.
Luye Pharma Group ’s (LYPHF) Commodity Channel Index (CCI) is 37.95, creating a Neutral signal.
Luye Pharma Group ’s (LYPHF) Price Rate of Change (ROC) is 3.45, creating a Buy signal.

FAQ

Is LYPHF a Buy, Hold, or Sell?
Based on LYPHF’s technical indicators, LYPHF is a Sell.
    What is LYPHF’s RSI (14)?
    LYPHF’s RSI (14) is 55.77, which suggests LYPHF is a Neutral.
      What is LYPHF’s MACD?
      LYPHF’s MACD is <0.01, which suggests LYPHF is a Sell.
        What is LYPHF’s 5-day moving average?
        LYPHF’s 5-day moving average is 0.31, which suggests LYPHF is a Sell.
          What is LYPHF’s 20-day moving average?
          LYPHF 20-day moving average is 0.29, which suggests LYPHF is a Buy.
            What is LYPHF’s 50-day moving average?
            LYPHF’s 50-day moving average is 0.28, which suggests LYPHF is a Buy.
              What is LYPHF’s 200-day moving average?
              LYPHF’s 200-day moving average is 0.34, which suggests LYPHF is a Sell.
                What is LYPHF’s Williams % R (14)?
                LYPHF’s Williams % R (14) is -47.90, which suggests LYPHF is a Buy.
                  What is LYPHF’s CCI (14)?
                  LYPHF’s CCI (14) is 37.95, which suggests LYPHF is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis